Similar articles

• Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study.

  Di Martino M, Agabiti N, Bauleo L, Kirchmayer U, Cascini S, Pistelli R, Colamesta V, Patorno E, Pinnarelli L, Fusco D, Perucci CA, Davoli M; OUTPUL Study Group. Di Martino M, et al. COPD. 2014 Aug;11(4):414-23. doi: 10.3109/15412555.2013.839646. Epub 2013 Oct 3. COPD. 2014. PMID: 24090036
• [Glycopyrronium bromide is a long-acting inhaled anticholinergic in the treatment of severe COPD].

  Ulrik CS. Ulrik CS. Ugeskr Laeger. 2013 Aug 26;175(35):1946-8. Ugeskr Laeger. 2013. PMID: 23978116 Review. Danish.
• The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.

  Beeh KM, Beier J. Beeh KM, et al. Adv Ther. 2010 Mar;27(3):150-9. doi: 10.1007/s12325-010-0017-6. Epub 2010 Apr 19. Adv Ther. 2010. PMID: 20411368 Review.
• Does the Term "Deflators" Reflect More Accurately the Beneficial Effects of Long-acting Bronchodilators in COPD?

  Kostikas K, Siafakas NM. Kostikas K, et al. COPD. 2016 Oct;13(5):537-9. doi: 10.3109/15412555.2016.1153615. Epub 2016 Apr 26. COPD. 2016. PMID: 27115572 No abstract available.
• The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients.

  Kim J, Kim K, Kim Y, Yoo KH, Lee CK, Yoon HK, Kim YS, Park YB, Lee JH, Oh YM, Lee SD, Lee SW. Kim J, et al. Respir Med. 2014 Jan;108(1):153-61. doi: 10.1016/j.rmed.2013.08.003. Epub 2013 Aug 30. Respir Med. 2014. PMID: 23993445